Skip to main content
. 2025 Jun 30;80(3):711–718. doi: 10.32592/ARI.2025.80.3.711

Table 2.

Hematological profiles, in control and treatment groups

Control AOM BV AOM+BV
WBCs (106/µl) 13.7 ± 1.24 21.73 ± 2.25*** 13.05 ± 0.81 15.6 ± 1.4**a
RBC (106/µl) 9.96 ± 0.12 5.15 ± 0.51*** 8.88 ± 0.18 8.02 ± 0.2 *b
Hb (g/dl) 15.85 ± 2.43 7.8 ± 0.38*** 14.7 ± 1.03 11.7 ± 0.2**c
Hct (%) 35.2 ± 0.67 29.4 ± 2.4** 34.8 ± 1.38 32.6 ± 1.3 *a
MCV (fl) 44.2 ± 0.67 33.2 ± 1.8** 43.2 ± 1.03 39.7 ± 2.2**a
MCH (pg) 22.8 ± 0.17 29.2 ± 0.1*** 21.43 ± 0.09 25.2 ± 0.1**a
MCHC (g/dl) 377 ± 5.8 522 ± 7.3*** 374 ± 4.61 420 ± 6.7**b

Data are given in mean ± standard error of the mean (SEM).

*

p<0.05,

**

p<0.01 and

***

p<0.001 are statistically different from control.

a

p<0.05,

b

p<0.01 and

c

p<0.001 are statistically different from AOM.

AOM: Azoxymethane (10mg/kg body weight, i.p once for 2 weeks).

BV: Bee venom (0.76 5mg/kg body weight, i.p for two weeks).